DOI QR코드

DOI QR Code

Compound heterozygous mutations of ACADS gene in newborn with short chain acyl-CoA dehydrogenase deficiency: case report and literatures review

  • An, Se Jin (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Kim, Sook Za (Korea Genetic Research Center) ;
  • Kim, Gu Hwan (Department of Medical Genetic Clinic and Laboratory, Asan Medical Center) ;
  • Yoo, Han Wook (Department of Medical Genetic Clinic and Laboratory, Asan Medical Center) ;
  • Lim, Han Hyuk (Department of Pediatrics, Chungnam National University School of Medicine)
  • Received : 2015.09.14
  • Accepted : 2015.10.28
  • Published : 2016.11.15

Abstract

Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is a rare autosomal recessive mitochondrial disorder of fatty acid ${\beta}$-oxidation, and is associated with mutations in the acyl-CoA dehydrogenase (ACADS) gene. Recent advances in spectrometric screening for inborn errors of metabolism have helped detect several metabolic disorders, including SCADD, without symptoms in the neonate period. This allows immediate initiation of treatment and monitoring, so they remain largely symptomless metabolic disease. Here, we report a 15-month-old asymptomatic male, who was diagnosed with SCADD by newborn screening. Spectrometric screening for inborn errors of metabolism 72 hours after birth revealed an elevated butyrylcarnitine (C4) concentration of $2.25{\mu}mol/L$ (normal, < $0.99{\mu}mol/L$). Urinary excretion of ethylmalonic acid was also elevated, as detected by urine organic acid analysis. To confirm the diagnosis of SCADD, direct sequencing analysis of 10 coding exons and the exon-intron boundaries of the ACADS gene were performed. Subsequent sequence analysis revealed compound heterozygous missense mutations c.164C>T (p.Pro55Leu) and c.1031A>G (p.Glu344Gly) on exons 2 and 9, respectively. The patient is now growing up, unretarded by symptoms such as seizure and developmental delay.

Keywords

References

  1. van Maldegem BT, Duran M, Wanders RJ, Waterham HR, Wijburg FA. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 2010;67:304-8. https://doi.org/10.1203/PDR.0b013e3181cbd57b
  2. van Maldegem BT, Wanders RJ, Wijburg FA. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2010;33:507-11.
  3. Amendt BA, Greene C, Sweetman L, Cloherty J, Shih V, Moon A, et al. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest 1987;79:1303-9. https://doi.org/10.1172/JCI112953
  4. Bok LA, Vreken P, Wijburg FA, Wanders RJ, Gregersen N, Corydon MJ, et al. Short-chain Acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder. Pediatrics 2003;112:1152-5. https://doi.org/10.1542/peds.112.5.1152
  5. Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab 2008;95:195-200. https://doi.org/10.1016/j.ymgme.2008.09.007
  6. Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P. Mitochondrial fatty acid oxidation defects: remaining challenges. J Inherit Metab Dis 2008;31:643-57. https://doi.org/10.1007/s10545-008-0990-y
  7. Lee HJ. Inborn errors of metabolism in Korea. J Korean Neurol Assoc 2004;22:1-10.
  8. Shirao K, Okada S, Tajima G, Tsumura M, Hara K, Yasunaga S, et al. Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl-CoA dehydrogenase deficiency. Hum Genet 2010;127:619-28. https://doi.org/10.1007/s00439-010-0822-7
  9. Naito E, Ozasa H, Ikeda Y, Tanaka K. Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest 1989;83:1605-13. https://doi.org/10.1172/JCI114058
  10. Gregersen N, Winter VS, Corydon MJ, Corydon TJ, Rinaldo P, Ribes A, et al. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduria. Hum Mol Genet 1998;7:619-27. https://doi.org/10.1093/hmg/7.4.619
  11. Corydon MJ, Gregersen N, Lehnert W, Ribes A, Rinaldo P, Kmoch S, et al. Ethylmalonic aciduria is associated with an amino acid variant of short chain acyl-coenzyme A dehydrogenase. Pediatr Res 1996;39:1059-66. https://doi.org/10.1203/00006450-199606000-00021
  12. Kim SZ, Jeon YM, Song WJ, Kim HS, Cho HY, Kil HR. Clinical and biochemical evaluation of institutionalized population with mental retardation or developmental delay. J Korean Soc Inherit Metab Dis 2012;12:94-8
  13. Kim SH, Park HD, Sohn YB, Park SW, Cho SY, Ji S, et al. Mutations of ACADS gene associated with short-chain acyl-coenzyme A dehydrogenase deficiency. Ann Clin Lab Sci 2011;41:84-8.
  14. Cheon CK, Choi HS, Kim SY, Yoo HW, Kim GH. Identification of novel compound heterozygous mutations in the ACADS gene of an asymptomatic Korean newborn with short chain acyl-coa dehydrogenase deficiency by tandem mass spectrometry. J Genet Med 2012;9:42-6. https://doi.org/10.5734/JGM.2012.9.1.42
  15. Park K, Ko JM, Jung G, Lee HC, Yoon SY, Ko SY, et al. A case of short-chain acyl-CoA dehydrogenase deficiency detected by newborn screening. J Korean Soc Inherit Metab Dis 2015;15:40-3.